相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms
Vincenza Cifarelli et al.
DIABETES (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
Xiang-Lin Tan et al.
PANCREAS (2015)
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
Wen Yue et al.
ONCOTARGET (2015)
Are Sulfonylurea and Insulin Therapies Associated With a Larger Risk of Cancer Than Metformin Therapy? A Retrospective Database Analysis
Bernd Kowall et al.
DIABETES CARE (2015)
Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study
Evan J. Walker et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium
C. Bosetti et al.
ANNALS OF ONCOLOGY (2014)
Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
Zheng Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells
Enrique Rozengurt
FRONTIERS IN PHYSIOLOGY (2014)
Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
Joanne W. Elena et al.
CANCER CAUSES & CONTROL (2013)
Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies
Jung-Yun Lee et al.
EUROPEAN JOURNAL OF CANCER (2013)
Hyperglycemia, Insulin Resistance, Impaired Pancreatic -Cell Function, and Risk of Pancreatic Cancer
Brian M. Wolpin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
New insights into pancreatic cancer-induced paraneoplastic diabetes
Raghuwansh P. Sah et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Increased Risk of Colon Cancer in Men in the Pre-Diabetes Phase
Adedayo A. Onitilo et al.
PLOS ONE (2013)
Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis
Jae Moon Yoon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Use of Insulin and Insulin Analogs and Risk of Cancer - Systematic Review and Meta-Analysis of Observational Studies
Oystein Karlstad et al.
CURRENT DRUG SAFETY (2013)
Diabetes and breast cancer risk: a meta-analysis
P. Boyle et al.
BRITISH JOURNAL OF CANCER (2012)
Adrenomedullin is Up-regulated in Patients With Pancreatic Cancer and Causes Insulin Resistance in β Cells and Mice
Gaurav Aggarwal et al.
GASTROENTEROLOGY (2012)
Prediabetes: a high-risk state for diabetes development
Adam G. Tabak et al.
LANCET (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Use of HbA1c in the diagnosis of diabetes
Andrew Farmer
BMJ-BRITISH MEDICAL JOURNAL (2012)
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
V. A. Grote et al.
DIABETOLOGIA (2011)
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Diabetes and risk of incident colorectal cancer in a prospective cohort of women
Andrew Flood et al.
CANCER CAUSES & CONTROL (2010)
Acute Pancreatitis in Association With Type 2 Diabetes and Antidiabetic Drugs A population-based cohort study
Antonio Gonzalez-Perez et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
P. D. Home et al.
DIABETOLOGIA (2010)
Prediabetes: The Importance of Early Identification and Intervention
Willa A. Hsueh et al.
POSTGRADUATE MEDICINE (2010)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Use of Angiotensin II Receptor Blockers and the Risk of Acute Pancreatitis: A Nested Case-Control Study
Tomas Sjoberg Bexelius et al.
PANCREATOLOGY (2009)
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
Rahul Pannala et al.
GASTROENTEROLOGY (2008)
Prediagnostic plasma c-pepticle and pancreatic cancer risk in men and women
Dominique S. Michaud et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research
James D. Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)